The TWEAK/Fn14/CD163 axis-implications for metabolic disease.

Reviews in Endocrine & Metabolic Disorders
Wiktoria RatajczakCatriona Kelly

Abstract

TWEAK (tumor necrosis factor-like weak inducer of apoptosis) is a member of the TNF superfamily that controls a multitude of cellular events including proliferation, migration, differentiation, apoptosis, angiogenesis, and inflammation. TWEAK control of these events is via an expanding list of intracellular signalling pathways which include NF-κB, ERK/MAPK, Notch, EGFR and AP-1. Two receptors have been identified for TWEAK - Fn14, which targets the membrane bound form of TWEAK, and CD163, which scavenges the soluble form of TWEAK. TWEAK appears to elicit specific events based on the receptor to which it binds, tissue type in which it is expressed, specific extrinsic conditions, and the presence of other cytokines. TWEAK signalling is protective in healthy tissues, but in chronic inflammatory states become detrimental to the tissue. Consistent data show a role for the TWEAK/FN14/CD163 axis in metabolic disease, chronic autoimmune diseases, and acute ischaemic stroke. Low circulating concentrations of soluble TWEAK are predictive of poor cardiovascular outcomes in those with and without diabetes. This review details the current understanding of the TWEAK/Fn14/CD163 axis as one of the chief regulators of immune signalling and its ...Continue Reading

References

Jan 24, 1998·The Journal of Biological Chemistry·Y ChicheporticheJ L Browning
Nov 9, 2000·The Journal of Experimental Medicine·M NakayamaH Yagita
Dec 9, 2000·Biochemical and Biophysical Research Communications·Y ChicheporticheS Izui
Jun 19, 2002·American Journal of Physiology. Regulatory, Integrative and Comparative Physiology·Timothy S Olson, Klaus Ley
Mar 5, 2003·Arteriosclerosis, Thrombosis, and Vascular Biology·Patrick J DonohueJeffrey A Winkles
Sep 4, 2004·Arteriosclerosis, Thrombosis, and Vascular Biology·Lena BrånénStefan Jovinge
Dec 25, 2004·The International Journal of Biochemistry & Cell Biology·Anne Grapin-Botton
Feb 1, 2005·The American Journal of Pathology·Manuel YepesJeffrey A Winkles
Jun 28, 2005·Atherosclerosis·Lina Panayiota AristoteliLeonard Kritharides
Dec 13, 2006·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·Jonas AxelssonPeter Stenvinkel
Jun 6, 2007·The Journal of Immunology : Official Journal of the American Association of Immunologists·Laura C BoverRenata Pasqualini
Apr 12, 2008·Nature Reviews. Drug Discovery·Jeffrey A Winkles
Sep 17, 2008·Journal of the Neurological Sciences·Ioana IntaMarkus Schwaninger
Oct 24, 2008·Clinical Journal of the American Society of Nephrology : CJASN·Juan J CarreroLuis M Blanco-Colio
Feb 10, 2009·The Journal of Immunology : Official Journal of the American Association of Immunologists·Mukesh KumarAshok Kumar
Feb 26, 2009·Protein Science : a Publication of the Protein Society·Fahu HeShigeyuki Yokoyama
May 12, 2009·Journal of Cellular and Molecular Medicine·Ana B SanzAlberto Ortiz
Jun 2, 2009·Cytokine & Growth Factor Reviews·Alberto OrtizLuis Miguel Blanco-Colio
Jul 2, 2009·Clinical Science·Jianli Niu, Pappachan E Kolattukudy
Sep 19, 2009·Arteriosclerosis, Thrombosis, and Vascular Biology·Kitty SchapiraSylvia Heeneman
Apr 14, 2010·The Journal of Biological Chemistry·Sharron A N BrownJeffrey A Winkles
Nov 26, 2010·Clinical Chemistry·Holger J MøllerAnne Tybjærg-Hansen
Dec 15, 2010·Advances in Experimental Medicine and Biology·Linda C Burkly, Taeko Dohi
Nov 24, 2011·ISRN Hematology·Xiaoyu Li, Harald von Boehmer
Jun 1, 2012·Journal of Signal Transduction·Mitali BhattacharjeeAditi Chatterjee
Jun 29, 2012·Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism·Kate Lykke LambertsenBente Finsen
Aug 8, 2012·Nature Reviews. Genetics·K G GuruharshaSpyros Artavanis-Tsakonas
Aug 21, 2012·Antioxidants & Redox Signaling·Anders Etzerodt, Søren K Moestrup
Mar 26, 2013·The EMBO Journal·Tatiana GoncharovDomagoj Vucic
Jun 21, 2013·The Journal of Clinical Endocrinology and Metabolism·Elsa Maymó-MasipMatilde R Chacón

❮ Previous
Next ❯

Related Concepts

Related Feeds

Autoimmune Diseases

Autoimmune diseases occur as a result of an attack by the immune system on the body’s own tissues resulting in damage and dysfunction. There are different types of autoimmune diseases, in which there is a complex and unknown interaction between genetics and the environment. Discover the latest research on autoimmune diseases here.

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis

Cell Migration

Cell migration is involved in a variety of physiological and pathological processes such as embryonic development, cancer metastasis, blood vessel formation and remoulding, tissue regeneration, immune surveillance and inflammation. Here is the latest research.